SG11202009526RA - Methods of treating ulcerative colitis - Google Patents
Methods of treating ulcerative colitisInfo
- Publication number
- SG11202009526RA SG11202009526RA SG11202009526RA SG11202009526RA SG11202009526RA SG 11202009526R A SG11202009526R A SG 11202009526RA SG 11202009526R A SG11202009526R A SG 11202009526RA SG 11202009526R A SG11202009526R A SG 11202009526RA SG 11202009526R A SG11202009526R A SG 11202009526RA
- Authority
- SG
- Singapore
- Prior art keywords
- methods
- ulcerative colitis
- treating ulcerative
- treating
- colitis
- Prior art date
Links
- 206010009900 Colitis ulcerative Diseases 0.000 title 1
- 201000006704 Ulcerative Colitis Diseases 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862650314P | 2018-03-30 | 2018-03-30 | |
| PCT/US2019/024633 WO2019191464A1 (en) | 2018-03-30 | 2019-03-28 | Methods of treating ulcerative colitis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202009526RA true SG11202009526RA (en) | 2020-10-29 |
Family
ID=66429483
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202009526RA SG11202009526RA (en) | 2018-03-30 | 2019-03-28 | Methods of treating ulcerative colitis |
Country Status (27)
| Country | Link |
|---|---|
| US (2) | US12152072B2 (pt) |
| EP (2) | EP4327866A3 (pt) |
| JP (4) | JP7119114B2 (pt) |
| KR (1) | KR102552693B1 (pt) |
| CN (1) | CN111936165A (pt) |
| AU (2) | AU2019243283C1 (pt) |
| BR (1) | BR112020018099A2 (pt) |
| CA (1) | CA3095297A1 (pt) |
| DK (1) | DK3773715T3 (pt) |
| EA (1) | EA202091989A1 (pt) |
| ES (1) | ES2983809T3 (pt) |
| FI (1) | FI3773715T3 (pt) |
| HR (1) | HRP20240904T1 (pt) |
| HU (1) | HUE067445T2 (pt) |
| IL (2) | IL277514B2 (pt) |
| LT (1) | LT3773715T (pt) |
| MA (1) | MA52216B1 (pt) |
| MD (1) | MD3773715T2 (pt) |
| MX (1) | MX2020010269A (pt) |
| PL (1) | PL3773715T3 (pt) |
| PT (1) | PT3773715T (pt) |
| RS (1) | RS65661B1 (pt) |
| SG (1) | SG11202009526RA (pt) |
| SI (1) | SI3773715T1 (pt) |
| TW (2) | TWI744617B (pt) |
| UA (1) | UA128578C2 (pt) |
| WO (1) | WO2019191464A1 (pt) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2020279987A1 (en) | 2019-05-23 | 2021-11-18 | Janssen Biotech, Inc. | Method of treating inflammatory bowel disease with a combination therapy of antibodies to IL-23 and TNF alpha |
| JP2023514567A (ja) * | 2020-02-14 | 2023-04-06 | ヤンセン バイオテツク，インコーポレーテツド | 抗ｉｌ１２／ｉｌ２３抗体で潰瘍性大腸炎を治療する安全かつ有効な方法 |
| AU2021276930A1 (en) | 2020-05-21 | 2023-02-02 | Janssen Biotech, Inc. | Method of treating inflammatory bowel disease with a combination therapy of antibodies to IL-23 and TNF alpha |
| JP7423815B2 (ja) * | 2020-10-20 | 2024-01-29 | セトラスホールディングス株式会社 | 治験管理装置、治験管理方法、治験管理プログラム及び治験管理システム |
| TW202241506A (zh) * | 2021-01-06 | 2022-11-01 | 美商艾伯維有限公司 | 治療克羅恩氏病及潰瘍性結腸炎之方法 |
| JP2024520202A (ja) * | 2021-05-20 | 2024-05-22 | ヤンセン バイオテツク，インコーポレーテツド | Ｉｌ－２３に対する抗体及びｔｎｆアルファに対する抗体の組み合わせ療法を用いた炎症性腸疾患を治療する方法 |
| US20240254217A1 (en) * | 2021-05-28 | 2024-08-01 | Eli Lilly And Company | Anti -il-23p19 antibody regulation of genes involved in ulcerative colitis |
| WO2024110898A1 (en) * | 2022-11-22 | 2024-05-30 | Janssen Biotech, Inc. | Method of treating ulcerative colitis with anti-il23 specific antibody |
| TW202500184A (zh) | 2023-03-10 | 2025-01-01 | 美商美國禮來大藥廠 | 治療潰瘍性結腸炎之方法 |
| WO2024255867A1 (zh) * | 2023-06-16 | 2024-12-19 | 信达生物制药(苏州)有限公司 | 重组抗白介素23p19亚基抗体在治疗炎症性肠病中的用途 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI1896073T1 (sl) * | 2005-06-30 | 2013-06-28 | Janssen Biotech, Inc. | Protitelesa proti il-23, sestavki, prostopki in uporabe |
| DK3219328T3 (da) | 2005-12-29 | 2020-07-13 | Janssen Biotech Inc | Humane anti-il-23-antistoffer, sammensætninger, fremgangsmåder og anvendelser |
| PT2426144T (pt) | 2007-02-23 | 2019-02-06 | Merck Sharp & Dohme | Anticorpos anti-il-23p19 fabricados por engenharia genética |
| EP2352762A1 (en) * | 2008-11-03 | 2011-08-10 | Schering Corporation | Inflammatory bowel disease biomarkers and related methods of treatment |
| JO3244B1 (ar) | 2009-10-26 | 2018-03-08 | Amgen Inc | بروتينات ربط مستضادات il – 23 البشرية |
| CA2816950C (en) * | 2010-11-04 | 2018-11-27 | Boehringer Ingelheim International Gmbh | Anti-il-23 antibodies |
| AR094877A1 (es) | 2013-03-08 | 2015-09-02 | Lilly Co Eli | Anticuerpos que se unen a il-23 |
| US20170002060A1 (en) * | 2014-01-08 | 2017-01-05 | Moderna Therapeutics, Inc. | Polynucleotides for the in vivo production of antibodies |
| JP7516250B2 (ja) * | 2018-03-05 | 2024-07-16 | ヤンセン バイオテツク，インコーポレーテツド | 抗ｉｌ－２３特異的抗体を用いたクローン病の治療方法 |
-
2019
- 2019-03-27 TW TW108110767A patent/TWI744617B/zh active
- 2019-03-27 TW TW110139868A patent/TWI837532B/zh active
- 2019-03-28 HR HRP20240904TT patent/HRP20240904T1/hr unknown
- 2019-03-28 IL IL277514A patent/IL277514B2/en unknown
- 2019-03-28 EA EA202091989A patent/EA202091989A1/ru unknown
- 2019-03-28 BR BR112020018099-8A patent/BR112020018099A2/pt unknown
- 2019-03-28 HU HUE19722256A patent/HUE067445T2/hu unknown
- 2019-03-28 US US16/981,915 patent/US12152072B2/en active Active
- 2019-03-28 ES ES19722256T patent/ES2983809T3/es active Active
- 2019-03-28 PT PT197222565T patent/PT3773715T/pt unknown
- 2019-03-28 SI SI201930750T patent/SI3773715T1/sl unknown
- 2019-03-28 IL IL312807A patent/IL312807B1/en unknown
- 2019-03-28 SG SG11202009526RA patent/SG11202009526RA/en unknown
- 2019-03-28 KR KR1020207027982A patent/KR102552693B1/ko active Active
- 2019-03-28 MX MX2020010269A patent/MX2020010269A/es unknown
- 2019-03-28 FI FIEP19722256.5T patent/FI3773715T3/fi active
- 2019-03-28 EP EP23215626.5A patent/EP4327866A3/en active Pending
- 2019-03-28 MA MA52216A patent/MA52216B1/fr unknown
- 2019-03-28 MD MDE20210135T patent/MD3773715T2/ro unknown
- 2019-03-28 EP EP19722256.5A patent/EP3773715B1/en active Active
- 2019-03-28 DK DK19722256.5T patent/DK3773715T3/da active
- 2019-03-28 JP JP2020552872A patent/JP7119114B2/ja active Active
- 2019-03-28 CA CA3095297A patent/CA3095297A1/en active Pending
- 2019-03-28 CN CN201980023563.3A patent/CN111936165A/zh active Pending
- 2019-03-28 LT LTEPPCT/US2019/024633T patent/LT3773715T/lt unknown
- 2019-03-28 PL PL19722256.5T patent/PL3773715T3/pl unknown
- 2019-03-28 AU AU2019243283A patent/AU2019243283C1/en active Active
- 2019-03-28 WO PCT/US2019/024633 patent/WO2019191464A1/en active Application Filing
- 2019-03-28 UA UAA202005571A patent/UA128578C2/uk unknown
- 2019-03-28 RS RS20240698A patent/RS65661B1/sr unknown
-
2022
- 2022-08-03 JP JP2022123689A patent/JP7331219B2/ja active Active
-
2023
- 2023-08-09 JP JP2023130117A patent/JP7571225B2/ja active Active
- 2023-10-11 AU AU2023248103A patent/AU2023248103A1/en active Pending
-
2024
- 2024-10-09 JP JP2024176901A patent/JP2025020134A/ja active Pending
- 2024-10-16 US US18/917,597 patent/US20250034243A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL277514A (en) | Methods for treating ulcerative colitis | |
| ZA202006746B (en) | Methods of treatment | |
| HK1259347A1 (zh) | 治療結腸炎的方法 | |
| ZA201903873B (en) | Methods of treating cochlear synaptopathy | |
| IL267199A (en) | A method for treating epilepsy | |
| IL290069A (en) | Methods for treating eye conditions | |
| HK1252692A1 (zh) | 治療或者預防蛋白質構象病的方法 | |
| IL272092A (en) | Methods for treating changes in behavior | |
| GB201815588D0 (en) | Method of treatment | |
| EP3684342C0 (en) | TREATMENT METHOD | |
| GB201706406D0 (en) | Method of treatment | |
| IL287130A (en) | Methods for treating itching | |
| IL279917A (en) | Treating ulcerative colitis with brazikumab | |
| PL3356577T3 (pl) | Obróbka w kąpieli wytrawiającej | |
| IL272379A (en) | Methods for treating cancer using SETDS inhibition | |
| GB201602802D0 (en) | Method of treatment | |
| SG11202005850VA (en) | Methods of treatment of hypertrigl yceridemia | |
| ZA201903931B (en) | Method of treating meat | |
| SG11201710199PA (en) | Methods of treating multiple sclerosis | |
| PT3661510T (pt) | Métodos de tratamento de alterações do comportamento | |
| GB201820157D0 (en) | Method of treatment | |
| GB201720439D0 (en) | Method of treatment | |
| ZA201805402B (en) | Treatment of contaminated water | |
| GB201718589D0 (en) | Method of treatment | |
| GB201801249D0 (en) | Methods of treatment |